Manulife (Manufacturers Life Insurance)
ORKA

Manulife (Manufacturers Life Insurance)’s Oruka Therapeutics ORKA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.56M Buy
72,563
+11,205
+18% +$389K ﹤0.01% 1275
2025
Q4 		$1.8M Buy
61,358
+9,450
+18% +$263K ﹤0.01% 1572
2025
Q3 		$998K Sell
51,908
-839
-2% -$12.4K ﹤0.01% 1854
2025
Q2 		$591K Buy
52,747
+9,828
+23% +$102K ﹤0.01% 2093
2025
Q1 		$440K Buy
42,919
+621
+1% +$7.75K ﹤0.01% 2207
2024
Q4 		$820K Hold
42,298
– – ﹤0.01% 1996
2024
Q3 		$1.04M Buy
+42,298
New +$1.47M ﹤0.01% 1907

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ORKA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Oruka Therapeutics (ORKA) stake by 18% in Q1 2026, buying an estimated $389K and bringing the position to 72,563 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

Manulife (Manufacturers Life Insurance) first reported a position in ORKA in Q3 2024 and has held it in 7 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 72,563 shares of Oruka Therapeutics worth $3.56M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 11,205 Oruka Therapeutics shares in Q1 2026, an estimated $389K.
  • Oruka Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1275 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.